Evidence map›Paper›PMID 38544831›Full record

ArticleFrontiers in oncology2024

Corrigendum: Glioblastoma survival is associated with distinct proteomic alteration signatures post chemoirradiation in a large-scale proteomic panel.

Andra Valentina Krauze, Michael Sierk, Trinh Nguyen, Qingrong Chen, Chunhua Yan, Ying Hu, William Jiang, Erdal Tasci, Theresa Cooley Zgela, Mary Sproull and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Andra Valentina KrauzeRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Michael SierkComputational Genomics and Bioinformatics Branch, Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Rockville, MD, United States.
Trinh NguyenComputational Genomics and Bioinformatics Branch, Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Rockville, MD, United States.
Qingrong ChenComputational Genomics and Bioinformatics Branch, Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Rockville, MD, United States.
Chunhua YanComputational Genomics and Bioinformatics Branch, Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Rockville, MD, United States.
Ying HuComputational Genomics and Bioinformatics Branch, Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Rockville, MD, United States.
William JiangRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Erdal TasciRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Theresa Cooley ZgelaRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Mary SproullRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Megan MackeyRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Uma ShankavaramRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.
Daoud MeerzamanComputational Genomics and Bioinformatics Branch, Center for Biomedical Informatics and Information Technology, National Cancer Institute, NIH, Rockville, MD, United States.
Kevin CamphausenRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, United States.

Funding

The Synergy Between Radiotherapy and Molecularly Targeted AgentsZIASC010373 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI CAMPHAUSEN, KEVIN · 2009 to 2025
$22.2M
Prognostic and predictive clinical and proteomic biomarker discovery in GBMZIABC012094 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KRAUZE, ANDRA · 2022 to 2025
$847k
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2023.1127645.].

Indexed as

classificationgenomicgliomaproteomicradiation

Identifiers

PMID38544831
PMCPMC10968889

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.